Entera Free Cash Flow Yield from 2010 to 2024

ENTX Stock  USD 1.64  0.06  3.53%   
Entera Bio Free Cash Flow Yield yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Yield will likely drop to -0.44 in 2024. Free Cash Flow Yield is a financial solvency ratio that compares the free cash flow per share Entera Bio is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. View All Fundamentals
 
Free Cash Flow Yield  
First Reported
2010-12-31
Previous Quarter
(0.42)
Current Value
(0.44)
Quarterly Volatility
0.20822228
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.76. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Free Cash Flow Yield Growth Pattern

Below is the plot of the Free Cash Flow Yield of Entera Bio over the last few years. It is a financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. Entera Bio's Free Cash Flow Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Yield10 Years Trend
Slightly volatile
   Free Cash Flow Yield   
       Timeline  

Entera Free Cash Flow Yield Regression Statistics

Arithmetic Mean(0.22)
Coefficient Of Variation(95.00)
Mean Deviation0.19
Median(0.09)
Standard Deviation0.21
Sample Variance0.04
Range0.5491
R-Value(0.80)
Mean Square Error0.02
R-Squared0.64
Significance0.0004
Slope(0.04)
Total Sum of Squares0.61

Entera Free Cash Flow Yield History

2024 -0.44
2023 -0.42
2022 -0.6
2021 -0.12
2020 -0.53
2019 -0.34
2018 -0.41

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Free Cash Flow Yield, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Yield(0.42)(0.44)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.